stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / PFE / Revenue

Pfizer Inc. Revenue 2007–2025

Pfizer Inc. (PFE) annual revenue by fiscal year, computed from SEC filings. Compound growth +1.4%/yr over 18 years.

Fiscal yearRevenueChange (YoY)
FY 2025$62.58B-1.6%
FY 2024$63.63B+8.8%
FY 2023$58.50B-41.7%
FY 2022$100.33B+23.4%
FY 2021$81.29B+95.2%
FY 2020$41.65B+1.8%
FY 2019$40.91B+0.2%
FY 2018$40.83B-22.3%
FY 2017$52.55B-0.5%
FY 2016$52.82B
FY 2015$0
FY 2014$0-100.0%
FY 2013$51.58B-5.6%
FY 2012$54.66B-10.4%
FY 2011$61.03B-6.3%
FY 2010$65.17B+32.3%
FY 2009$49.27B+2.0%
FY 2008$48.30B-0.3%
FY 2007$48.42B

Source: Pfizer Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Pfizer Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Pfizer Inc. — frequently asked questions

What is Pfizer Inc.'s revenue?

Pfizer Inc. (PFE) reported revenue of $62.58B for fiscal year 2025, per its SEC filings.

How has Pfizer Inc.'s revenue changed over time?

Between fiscal 2007 and 2025, PFE's revenue grew at roughly 1.4% per year (compound annual rate), from $48.42B to $62.58B.

Where does this data come from?

Figures are computed from Pfizer Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More PFE financial history

Full PFE fundamentals page → · All 1,500+ companies →